Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. P
7. KKR
8. HPQ
9. NTNX
10. SNPS

Go back to Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site
(AMEX: KRBP) Delayed: 0.16 --0 (-0%)
Previous Close $0.16    52 Week High $ 
Open $0.16    52 Week Low $ 
Day High $0.16    P/E N/A 
Day Low $0.16    EPS $ 
Volume 195,559